Eosinophils: Biological Properties and Role in Health and Disease

Eosinophils are pleiotropic multifunctional leukocytes involved in initiation and propagation of diverse inflammatory responses, as well as modulators of innate and adaptive immunity. In this review, the biology of eosinophils is summarized, focusing on transcriptional regulation of eosinophil differentiation, characterization of the growing properties of eosinophil granule proteins, surface proteins and pleiotropic mediators, and molecular mechanisms of eosinophil degranulation. New views on the role of eosinophils in homeostatic function are examined, including developmental biology and innate and adaptive immunity (as well as their interaction with mast cells and T cells) and their proposed role in disease processes including infections, asthma, and gastrointestinal disorders. Finally, strategies for targeted therapeutic intervention in eosinophil‐mediated mucosal diseases are conceptualized.

[1]  D. Loegering,et al.  The effect of purified human eosinophil major basic protein on mammalian ciliary activity. , 2015, The American review of respiratory disease.

[2]  S. Phipps,et al.  Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. , 2007, Blood.

[3]  Francesca Levi-Schaffer,et al.  Inhibitory receptors on eosinophils: a direct hit to a possible Achilles heel? , 2007, The Journal of allergy and clinical immunology.

[4]  D. Robinson,et al.  Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. , 2007, American journal of respiratory and critical care medicine.

[5]  Paul E Moore,et al.  Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation. , 2007, American journal of respiratory and critical care medicine.

[6]  M. Collins,et al.  Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. , 2006, The Journal of allergy and clinical immunology.

[7]  L. Fabbri,et al.  Epithelial damage and angiogenesis in the airways of children with asthma. , 2006, American journal of respiratory and critical care medicine.

[8]  G. Gleich,et al.  Eosinophil-Derived Cationic Proteins Activate the Synthesis of Remodeling Factors by Airway Epithelial Cells1 , 2006, The Journal of Immunology.

[9]  James J. Lee,et al.  Schistosoma mansoni infection in eosinophil lineage-ablated mice. , 2006, Blood.

[10]  J. Musial,et al.  Increased expression of collagen receptors: α1β1 and α2β1 integrins on blood eosinophils in bronchial asthma , 2006 .

[11]  Li Lin,et al.  [Pathogenesis of respiratory syncytial virus infection]. , 2006, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[12]  S. Cormier,et al.  Exposure of neonates to Respiratory Syncytial Virus is critical in determining subsequent airway response in adults , 2006, Respiratory research.

[13]  P. Foster,et al.  ICAM‐1‐dependent pathways regulate colonic eosinophilic inflammation , 2006, Journal of leukocyte biology.

[14]  S. Kunkel,et al.  Respiratory viral infections drive chemokine expression and exacerbate the asthmatic response , 2006, Journal of Allergy and Clinical Immunology.

[15]  Marc E. Rothenberg,et al.  CD48 Is an Allergen and IL-3-Induced Activation Molecule on Eosinophils1 , 2006, The Journal of Immunology.

[16]  K. Akashi,et al.  C/EBPβ is required for 'emergency' granulopoiesis , 2006, Nature Immunology.

[17]  P. Kincade.  Supplying the demand for granulocytes , 2006, Nature Immunology.

[18]  H. Kita,et al.  A critical role for vesicle‐associated membrane protein‐7 in exocytosis from human eosinophils and neutrophils , 2006, Allergy.

[19]  H. Simon,et al.  Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. , 2006, The Journal of allergy and clinical immunology.

[20]  David A. Williams,et al.  The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease. , 2006, Blood.

[21]  J. Weinstock,et al.  Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma , 2006, The Journal of experimental medicine.

[22]  N. Jarjour,et al.  Dissection of the hyperadhesive phenotype of airway eosinophils in asthma. , 2006, American journal of respiratory cell and molecular biology.

[23]  H. Renz,et al.  Airway epithelial cells produce neurotrophins and promote the survival of eosinophils during allergic airway inflammation. , 2006, The Journal of allergy and clinical immunology.

[24]  Chang Keun Kim,et al.  Increased levels of BAL cysteinyl leukotrienes in acute RSV bronchiolitis , 2006 .

[25]  Chang Keun Kim,et al.  Increased levels of BAL cysteinyl leukotrienesinacute [corrected] RSV bronchiolitis. , 2006, Acta paediatrica.

[26]  M. Everard.  The role of the respiratory syncytial virus in airway syndromes in childhood , 2006, Current allergy and asthma reports.

[27]  T. Wynn,et al.  Interleukin-5 (IL-5) Augments the Progression of Liver Fibrosis by Regulating IL-13 Activity , 2006, Infection and Immunity.

[28]  I. Hall,et al.  Eosinophil-mediated cholinergic nerve remodeling. , 2006, American journal of respiratory cell and molecular biology.

[29]  D. Loegering,et al.  Major Basic Protein Homolog (MBP2): A Specific Human Eosinophil Marker1 , 2006, The Journal of Immunology.

[30]  B. Aronow,et al.  Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. , 2006, The Journal of clinical investigation.

[31]  A. Slungaard,et al.  Role of eosinophil peroxidase in host defense and disease pathology. , 2006, Archives of biochemistry and biophysics.

[32]  A. Fryer,et al.  Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction. , 2005, The Journal of clinical investigation.

[33]  Hiroshi Tanaka,et al.  Interferon-gamma up-regulates expression of cysteinyl leukotriene type 2 receptors on eosinophils in asthmatic patients. , 2005, Chest.

[34]  James J. Lee,et al.  Eosinophils alter colonic epithelial barrier function: role for major basic protein. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[35]  J. Devincenzo,et al.  Factors Predicting Childhood Respiratory Syncytial Virus Severity: What They Indicate About Pathogenesis , 2005, The Pediatric infectious disease journal.

[36]  W. Forssmann,et al.  Differential pattern of CCR1 internalization in human eosinophils: prolonged internalization by CCL5 in contrast to CCL3 , 2005, Allergy.

[37]  M. Karow,et al.  The Eotaxin Chemokines and CCR3 Are Fundamental Regulators of Allergen-Induced Pulmonary Eosinophilia1 , 2005, The Journal of Immunology.

[38]  G. Piedimonte,et al.  Palivizumab in the prophylaxis of respiratory syncytial virus infection , 2005, Expert review of anti-infective therapy.

[39]  I. Jónsdóttir,et al.  Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. , 2005, The Journal of allergy and clinical immunology.

[40]  R. Pecova,et al.  Induced sputum eosinophils, bronchial reactivity, and cough sensitivity in subjects with allergic rhinitis. , 2005, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[41]  N. Lee,et al.  Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function? , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[42]  M. Rothenberg,et al.  Inhibition of human interleukin‐13‐induced respiratory and oesophageal inflammation by anti‐human‐interleukin‐13 antibody (CAT‐354) , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[43]  David A. Williams,et al.  CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism. , 2005, Blood.

[44]  J. Tregoning,et al.  Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection , 2005, Clinical Microbiology Reviews.

[45]  William W. Busse,et al.  Allergy and asthma. , 2005, The Journal of allergy and clinical immunology.

[46]  Nikolaos M. Nikolaidis,et al.  Identification of a Cooperative Mechanism Involving Interleukin-13 and Eotaxin-2 in Experimental Allergic Lung Inflammation* , 2005, Journal of Biological Chemistry.

[47]  V. Zinchuk,et al.  Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis. , 2005, Molecular vision.

[48]  Yusuke Suzuki,et al.  Prostaglandin D2-Induced Eosinophilic Airway Inflammation Is Mediated by CRTH2 Receptor , 2005, Journal of Pharmacology and Experimental Therapeutics.

[49]  O. Mandelboim,et al.  2B4 (CD244) Is Expressed and Functional on Human Eosinophils1 , 2005, The Journal of Immunology.

[50]  S. Phipps,et al.  Acute allergen-induced airway remodeling in atopic asthma. , 2004, American journal of respiratory cell and molecular biology.

[51]  A. Ghahary,et al.  Cutting Edge: Human Eosinophils Regulate T Cell Subset Selection through Indoleamine 2,3-Dioxygenase1 , 2004, The Journal of Immunology.

[52]  F. Finkelman,et al.  Basophils Initiate IL-4 Production during a Memory T-dependent Response , 2004, The Journal of experimental medicine.

[53]  T. Wynn,et al.  Immunopathogenesis of schistosomiasis , 2004, Immunological reviews.

[54]  E. Pearce,et al.  Th2 response polarization during infection with the helminth parasite Schistosoma mansoni , 2004, Immunological reviews.

[55]  E. Lenkiewicz,et al.  Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.

[56]  S. Orkin,et al.  A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.

[57]  Huanzhong Shi.  Eosinophils function as antigen‐presenting cells , 2004, Journal of leukocyte biology.

[58]  S. Phipps,et al.  A role for eosinophils in airway remodelling in asthma. , 2004, Trends in immunology.

[59]  P. Vyas,et al.  Deletion of the major GATA1 enhancer HS 1 does not affect eosinophil GATA1 expression and eosinophil differentiation. , 2004, Blood.

[60]  Jack A. Elias,et al.  Acidic Mammalian Chitinase in Asthmatic Th2 Inflammation and IL-13 Pathway Activation , 2004, Science.

[61]  E. Pearce,et al.  Association of Type 2 Cytokines with Hepatic Fibrosis in Human Schistosoma mansoni Infection , 2004, Infection and Immunity.

[62]  S. Phipps,et al.  Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin. , 2004, The Journal of investigative dermatology.

[63]  James J. Lee,et al.  Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen , 2004, Journal of leukocyte biology.

[64]  C. Huynh,et al.  Identification of SNAREs Involved in Synaptotagmin VII-regulated Lysosomal Exocytosis* , 2004, Journal of Biological Chemistry.

[65]  Q. Hamid,et al.  IL-9 in Allergic Inflammation , 2004, International Archives of Allergy and Immunology.

[66]  K. Offord,et al.  Treatment of asthma with nebulized lidocaine: a randomized, placebo-controlled study. , 2004, The Journal of allergy and clinical immunology.

[67]  N. Lukacs,et al.  Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. , 2004, The Journal of infectious diseases.

[68]  T. Haverty,et al.  Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. , 2004, Blood.

[69]  P. Marynen,et al.  The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. , 2004, Blood.

[70]  P. Helms,et al.  Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[71]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[72]  S. Chakrabarti,et al.  p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils. , 2004, Biochemical and biophysical research communications.

[73]  D. Voehringer,et al.  Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. , 2004, Immunity.

[74]  P. O'Byrne,et al.  Sputum CD34+IL-5Rα+Cells Increase after Allergen: Evidence forIn SituEosinophilopoiesis , 2004 .

[75]  P. O'Byrne,et al.  Kinetics of bone marrow eosinophilopoiesis and associated cytokines after allergen inhalation. , 2004, American journal of respiratory and critical care medicine.

[76]  T. Kimman,et al.  Respiratory syncytial virus, pneumonia virus of mice, and influenza A virus differently affect respiratory allergy in mice , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[77]  K. Takatsu,et al.  Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice. , 2004, American journal of respiratory cell and molecular biology.

[78]  D. Broide,et al.  Inhibition of airway remodeling in IL-5-deficient mice. , 2004, The Journal of clinical investigation.

[79]  D. Metcalfe,et al.  Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. , 2004, Blood.

[80]  P. Marynen,et al.  The FIP1L1-PDGFR&agr; kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia , 2004, Current opinion in hematology.

[81]  H-Z Shi,et al.  Endobronchial eosinophils preferentially stimulate T helper cell type 2 responses , 2003, Allergy.

[82]  C. Ferland,et al.  Expression of membrane type-4 matrix metalloproteinase (metalloproteinase-17) by human eosinophils. , 2003, The international journal of biochemistry & cell biology.

[83]  M. Goldman,et al.  The hypereosinophilic syndrome revisited. , 2003, Annual review of medicine.

[84]  G. Gleich,et al.  Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization. , 2003, The Journal of allergy and clinical immunology.

[85]  M. Kojima,et al.  Mouse model of airway remodeling: strain differences. , 2003, American journal of respiratory and critical care medicine.

[86]  S. Phipps,et al.  Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. , 2003, The Journal of clinical investigation.

[87]  G. Gleich,et al.  Eosinophil Major Basic Protein Stimulates Neutrophil Superoxide Production by a Class IA Phosphoinositide 3-Kinase and Protein Kinase C-ζ-Dependent Pathway1 , 2003, The Journal of Immunology.

[88]  H. Hoogsteden,et al.  Airway Eosinophils Accumulate in the Mediastinal Lymph Nodes but Lack Antigen-Presenting Potential for Naive T Cells 1 , 2003, The Journal of Immunology.

[89]  H. Kantarjian,et al.  Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. , 2003, Blood.

[90]  B. Bochner,et al.  Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. , 2003, Blood.

[91]  D. Gilliland,et al.  Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. , 2003, Blood.

[92]  T. Williams,et al.  Variations in Eosinophil Chemokine Responses: An Investigation of CCR1 and CCR3 Function, Expression in Atopy, and Identification of a Functional CCR1 Promoter1 , 2003, The Journal of Immunology.

[93]  D. Postma,et al.  Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. , 2003, American journal of respiratory and critical care medicine.

[94]  M. Caligiuri,et al.  Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[95]  I. Pavord,et al.  Comparison of airway immunopathology of eosinophilic bronchitis and asthma , 2003, Thorax.

[96]  P. Goyal,et al.  Responses of inbred mouse strains to infection with intestinal nematodes , 2003, Journal of Helminthology.

[97]  M. Aubier,et al.  Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.

[98]  R. Moqbel,et al.  Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion. , 2003, The Journal of allergy and clinical immunology.

[99]  Bruce E. Torbett,et al.  Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBPε and PU.1 , 2003 .

[100]  Peter Marynen,et al.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. , 2003, The New England journal of medicine.

[101]  Paige Lacy,et al.  Divergence of Mechanisms Regulating Respiratory Burst in Blood and Sputum Eosinophils and Neutrophils from Atopic Subjects1 , 2003, The Journal of Immunology.

[102]  P. Foster,et al.  Chemokines in asthma: cooperative interaction between chemokines and IL-13. , 2003, The Journal of allergy and clinical immunology.

[103]  S. Phipps,et al.  Effect of intravenous administration of an anti-IL-5 mAb (Mepolizumab) on allergen-induced tissue eosinophilia, the late-phase allergic reaction and the expression of a marker of repair/remodeling in human atopic subjects , 2003 .

[104]  P. Piedra.  Clinical experience with respiratory syncytial virus vaccines , 2003, The Pediatric infectious disease journal.

[105]  A. Kay,et al.  Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. , 2003, American journal of respiratory and critical care medicine.

[106]  B. Engelhardt,et al.  Alpha4 integrins as therapeutic targets in autoimmune disease. , 2003, The New England journal of medicine.

[107]  R. Locksley,et al.  Helper T cells regulate type-2 innate immunity in vivo , 2002, Nature.

[108]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[109]  P. Openshaw,et al.  Age at First Viral Infection Determines the Pattern of T Cell–mediated Disease during Reinfection in Adulthood , 2002, The Journal of experimental medicine.

[110]  Jonathan E. Schmitz,et al.  Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBPε Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein* , 2002, The Journal of Biological Chemistry.

[111]  M. Collins,et al.  Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry. , 2002, The Journal of pediatrics.

[112]  L. J. Woods,et al.  Intracrine Cysteinyl Leukotriene Receptor–mediated Signaling of Eosinophil Vesicular Transport–mediated Interleukin-4 Secretion , 2002, The Journal of experimental medicine.

[113]  F. Levi-Schaffer,et al.  Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation. , 2002, Molecular immunology.

[114]  Kazuhiko Yamamoto,et al.  A Functional Study on CysLT1 Receptors in Human Eosinophils , 2002, International Archives of Allergy and Immunology.

[115]  H. Kantarjian,et al.  Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate. , 2002, Leukemia research.

[116]  A. Kay,et al.  Eotaxin (CCL11) and Eotaxin-2 (CCL24) Induce Recruitment of Eosinophils, Basophils, Neutrophils, and Macrophages As Well As Features of Early- and Late-Phase Allergic Reactions Following Cutaneous Injection in Human Atopic and Nonatopic Volunteers1 , 2002, The Journal of Immunology.

[117]  G. Reed,et al.  Vesicle-associated membrane protein 3 (VAMP-3) and VAMP-8 are present in human platelets and are required for granule secretion. , 2002, Blood.

[118]  S. Nurko,et al.  Eosinophilic esophagitis: It[apos ]s not just kid[apos ]s stuff , 2002 .

[119]  J. Douwes,et al.  Non-eosinophilic asthma: importance and possible mechanisms , 2002, Thorax.

[120]  S. Orkin,et al.  Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo , 2002, The Journal of experimental medicine.

[121]  A. Iwama,et al.  Essential and Instructive Roles of GATA Factors in Eosinophil Development , 2002, The Journal of experimental medicine.

[122]  T. Graf,et al.  Making Eosinophils Through Subtle Shifts in Transcription Factor Expression , 2002, The Journal of experimental medicine.

[123]  J. Penrose,et al.  Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils. , 2002, The Journal of allergy and clinical immunology.

[124]  M. Ebisawa,et al.  Cross-Talk between Integrins and Chemokines That Influences Eosinophil Adhesion and Migration , 2002, International Archives of Allergy and Immunology.

[125]  C. Martínez-A,et al.  Increased responsiveness of murine eosinophils to MIP‐1β (CCL4) and TCA‐3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8 , 2002, Journal of leukocyte biology.

[126]  I. Pavord,et al.  Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.

[127]  Jiang Zhu,et al.  Hematopoietic cytokines, transcription factors and lineage commitment , 2002, Oncogene.

[128]  A. Tefferi,et al.  Treatment of hypereosinophilic syndrome with imatinib mesilate , 2002, The Lancet.

[129]  S. Dower,et al.  Toll-Like Receptor (TLR)2 and TLR4 in Human Peripheral Blood Granulocytes: A Critical Role for Monocytes in Leukocyte Lipopolysaccharide Responses1 , 2002, The Journal of Immunology.

[130]  G. J. Swaminathan,et al.  Charcot-Leyden Crystal Protein (Galectin-10) Is Not a Dual Function Galectin with Lysophospholipase Activity but Binds a Lysophospholipase Inhibitor in a Novel Structural Fashion* , 2002, The Journal of Biological Chemistry.

[131]  D. Tenen,et al.  Reciprocal Roles for CCAAT/Enhancer Binding Protein (C/EBP) and PU.1 Transcription Factors in Langerhans Cell Commitment , 2002, The Journal of experimental medicine.

[132]  R. Geha,et al.  CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. , 2002, The Journal of clinical investigation.

[133]  P. Foster,et al.  Enterocyte Expression of the Eotaxin and Interleukin-5 Transgenes Induces Compartmentalized Dysregulation of Eosinophil Trafficking* , 2002, The Journal of Biological Chemistry.

[134]  D. Friend,et al.  The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[135]  Paige Lacy,et al.  Expression of eosinophil target SNAREs as potential cognate receptors for vesicle-associated membrane protein-2 in exocytosis. , 2002, The Journal of allergy and clinical immunology.

[136]  Jing Zhao,et al.  Altered eosinophil levels as a result of viral infection in asthma exacerbation in childhood , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[137]  M. Mascarenhas,et al.  The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. , 2002, The Journal of allergy and clinical immunology.

[138]  M. Trevethick,et al.  IDENTIFICATION OF A HISTAMINE H4 RECEPTOR ON HUMAN EOSINOPHILS—ROLE IN EOSINOPHIL CHEMOTAXIS , 2002, Journal of receptor and signal transduction research.

[139]  E. Israel,et al.  Variant eotaxin: its effects on the asthma phenotype. , 2001, The Journal of allergy and clinical immunology.

[140]  M. Collins,et al.  Pathogenesis and clinical features of eosinophilic esophagitis. , 2001, The Journal of allergy and clinical immunology.

[141]  H. Rosenberg,et al.  Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens , 2001, Journal of leukocyte biology.

[142]  J. Pollard,et al.  Eotaxin Is Required for Eosinophil Homing into the Stroma of the Pubertal and Cycling Uterus. , 2001, Endocrinology.

[143]  P. O'Byrne,et al.  The trials and tribulations of IL-5, eosinophils, and allergic asthma. , 2001, The Journal of allergy and clinical immunology.

[144]  P. Foster,et al.  Eosinophils Promote Allergic Disease of the Lung by Regulating CD4+ Th2 Lymphocyte Function1 , 2001, The Journal of Immunology.

[145]  Schaller Jl,et al.  Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate. , 2001 .

[146]  R. Garofalo,et al.  Macrophage Inflammatory Protein-1α (Not T Helper Type 2 Cytokines) Is Associated with Severe Forms of Respiratory Syncytial Virus Bronchiolitis , 2001 .

[147]  S. Hazen,et al.  Extensive Eosinophil Degranulation and Peroxidase-Mediated Oxidation of Airway Proteins Do Not Occur in a Mouse Ovalbumin-Challenge Model of Pulmonary Inflammation1 , 2001, The Journal of Immunology.

[148]  F. Levi-Schaffer,et al.  Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions. , 2001, The Journal of allergy and clinical immunology.

[149]  P. Foster,et al.  A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation , 2001, Nature Immunology.

[150]  Paige Lacy,et al.  Fusion protein vesicle-associated membrane protein 2 is implicated in IFN-gamma-induced piecemeal degranulation in human eosinophils from atopic individuals. , 2001, The Journal of allergy and clinical immunology.

[151]  M. Rothenberg.  Gastrointestinal eosinophils , 2001, Allergy.

[152]  R. Dahl,et al.  SNARE proteins are critical for regulated exocytosis of ECP from human eosinophils. , 2001, Biochemical and biophysical research communications.

[153]  R. Flaumenhaft,et al.  Ultrastructural Localization of Vesicle-associated Membrane Protein(s) to Specialized Membrane Structures in Human Pericytes, Vascular Smooth Muscle Cells, Endothelial Cells, Neutrophils, and Eosinophils , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[154]  W. Parks,et al.  Bromination of deoxycytidine by eosinophil peroxidase: a mechanism for mutagenesis by oxidative damage of nucleotide precursors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[155]  A. McKenzie,et al.  Elemental signals regulating eosinophil accumulation in the lung , 2001, Immunological reviews.

[156]  R. Schleimer,et al.  Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment , 2001, Immunological reviews.

[157]  K. Sugamura,et al.  Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.

[158]  G. Walsh.  Eosinophil granule proteins and their role in disease , 2001, Current opinion in hematology.

[159]  K. Chung,et al.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.

[160]  K. Ohta,et al.  Glucocorticoids preferentially upregulate functional CXCR4 expression in eosinophils. , 2000, The Journal of allergy and clinical immunology.

[161]  F. Finkelman,et al.  Murine Eotaxin-2: A Constitutive Eosinophil Chemokine Induced by Allergen Challenge and IL-4 Overexpression1 , 2000, The Journal of Immunology.

[162]  J. Stankova,et al.  IL-5 Up-Regulates Cysteinyl Leukotriene 1 Receptor Expression in HL-60 Cells Differentiated into Eosinophils1 , 2000, The Journal of Immunology.

[163]  J. L. Kavanaugh,et al.  Analysis of the CC chemokine receptor 3 gene reveals a complex 5' exon organization, a functional role for untranslated exon 1, and a broadly active promoter with eosinophil-selective elements. , 2000, Blood.

[164]  H. Rosenberg,et al.  The Chemokine Macrophage-Inflammatory Protein-1α and Its Receptor CCR1 Control Pulmonary Inflammation and Antiviral Host Defense in Paramyxovirus Infection , 2000, The Journal of Immunology.

[165]  D. James,et al.  Syntaxin 7 is localized to late endosome compartments, associates with Vamp 8, and Is required for late endosome-lysosome fusion. , 2000, Molecular biology of the cell.

[166]  A. Herbelin,et al.  CD11c+ Eosinophils in the Murine Thymus: Developmental Regulation and Recruitment upon MHC Class I-Restricted Thymocyte Deletion , 2000, The Journal of Immunology.

[167]  M. Rothenberg,et al.  Peyer's patch eosinophils: identification, characterization, and regulation by mucosal allergen exposure, interleukin-5, and eotaxin. , 2000, Blood.

[168]  J. Pevsner,et al.  Syntaxin 7 and VAMP-7 are soluble N-ethylmaleimide-sensitive factor attachment protein receptors required for late endosome-lysosome and homotypic lysosome fusion in alveolar macrophages. , 2000, Molecular biology of the cell.

[169]  A. Wardlaw.  The role of adhesion in eosinophil function. , 2000, Chemical immunology.

[170]  T. Galli,et al.  Soluble NSF Attachment Protein Receptors (SNAREs) in RBL-2H3 Mast Cells: Functional Role of Syntaxin 4 in Exocytosis and Identification of a Vesicle-Associated Membrane Protein 8-Containing Secretory Compartment1 , 2000, The Journal of Immunology.

[171]  J. Pollard,et al.  Postnatal mammary gland development requires macrophages and eosinophils. , 2000, Development.

[172]  H. Singh,et al.  Regulation of B lymphocyte and macrophage development by graded expression of PU.1. , 2000, Science.

[173]  S. Hazen,et al.  Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical. , 2000, Biochemistry.

[174]  P. Loke,et al.  Interleukin-5 Is Essential for Vaccine-Mediated Immunity but Not Innate Resistance to a Filarial Parasite , 2000, Infection and Immunity.

[175]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[176]  K. Ovington,et al.  The role of eosinophils in parasitic helminth infections: insights from genetically modified mice. , 2000, Parasitology today.

[177]  N. Hirashima,et al.  Rat basophilic leukemia cells express syntaxin-3 and VAMP-7 in granule membranes. , 2000, Biochemical and biophysical research communications.

[178]  P. Weller,et al.  Lymph node trafficking and antigen presentation by endobronchial eosinophils. , 2000, The Journal of clinical investigation.

[179]  B. Bochner,et al.  The surface phenotype of human eosinophils. , 2000, Chemical immunology.

[180]  K. Dyer,et al.  Pulmonary eosinophilia and production of MIP-1alpha are prominent responses to infection with pneumonia virus of mice. , 2000, Cellular immunology.

[181]  A. Balic,et al.  Do eosinophils have a role in the killing of helminth parasites? , 2000, Parasitology today.

[182]  C. Serhan,et al.  Cutting Edge: Lipoxin (LX) A4 and Aspirin-Triggered 15-Epi-LXA4 Block Allergen-Induced Eosinophil Trafficking1 , 2000, The Journal of Immunology.

[183]  P. Desreumaux,et al.  Activated eosinophils in inflammatory bowel disease: do they matter? , 1999, American Journal of Gastroenterology.

[184]  J. White,et al.  Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. , 1999, Journal of immunology.

[185]  G. Gleich,et al.  Ovalbumin Sensitization Changes the Inflammatory Response to Subsequent Parainfluenza Infection , 1999, The Journal of experimental medicine.

[186]  S. Durham,et al.  The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. , 1999, Immunology today.

[187]  R. Moqbel,et al.  Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. , 1999, The Journal of allergy and clinical immunology.

[188]  A. Wardlaw.  Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm. , 1999, The Journal of allergy and clinical immunology.

[189]  J. Farber,et al.  MIP‐3α induces human eosinophil migration and activation of the mitogen‐activated protein kinases (p42/p44 MAPK) , 1999, Journal of leukocyte biology.

[190]  R. Scheller,et al.  Vamp-7 Mediates Vesicular Transport from Endosomes to Lysosomes , 1999, The Journal of cell biology.

[191]  A. Capron,et al.  Expression of Cd28 and Cd86 by Human Eosinophils and Role in the Secretion of Type 1 Cytokines (Interleukin 2 and Interferon γ) , 1999, The Journal of experimental medicine.

[192]  P. O'Byrne,et al.  Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. , 1999, American journal of respiratory and critical care medicine.

[193]  T. Nishi,et al.  A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. , 1999, Journal of immunology.

[194]  G. Gleich,et al.  Stimulation of neutrophil interleukin-8 production by eosinophil granule major basic protein. , 1999, American journal of respiratory cell and molecular biology.

[195]  W. Hsueh,et al.  Platelet-activating factor receptor mRNA is localized in eosinophils and epithelial cells in rat small intestine: regulation by dexamethasone and gut flora. , 1999, Immunology.

[196]  Paige Lacy,et al.  Rapid mobilization of intracellularly stored RANTES in response to interferon-gamma in human eosinophils. , 1999, Blood.

[197]  B. Haselden,et al.  Immunoglobulin E–independent Major Histocompatibility Complex–restricted T Cell Peptide Epitope–induced Late Asthmatic Reactions , 1999, The Journal of experimental medicine.

[198]  James J. Lee,et al.  Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. , 1999, The Journal of clinical investigation.

[199]  M. Lindsay,et al.  Pharmacology of the eosinophil. , 1999, Pharmacological reviews.

[200]  R. Scheller,et al.  Vesicle-associated membrane protein 4 is implicated in trans-Golgi network vesicle trafficking. , 1999, Molecular biology of the cell.

[201]  M. Seminario,et al.  Intracellular Expression and Release of FcεRIα by Human Eosinophils , 1999, The Journal of Immunology.

[202]  H. Rosenberg,et al.  Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. , 1999, American journal of respiratory and critical care medicine.

[203]  H. Kita,et al.  Does IgE bind to and activate eosinophils from patients with allergy? , 1999, Journal of immunology.

[204]  M. Seminario,et al.  Intracellular expression and release of Fc epsilon RI alpha by human eosinophils. , 1999, Journal of Immunology.

[205]  H. Sampson,et al.  Food allergy. Part 1: immunopathogenesis and clinical disorders. , 1999, The Journal of allergy and clinical immunology.

[206]  A. Proudfoot,et al.  The CC Chemokine Receptor Antagonist Met–RANTES Inhibits Eosinophil Effector Functions , 1999, International Archives of Allergy and Immunology.

[207]  A. Bousvaros,et al.  Allergic esophagitis in children: a clinicopathological entity. , 1999, The American journal of surgical pathology.

[208]  J. Kim,et al.  Ligation of Fc gamma RII (CD32) pivotally regulates survival of human eosinophils. , 1999, Journal of immunology.

[209]  H. Tomioka,et al.  Signal Transduction through Interferon–Gamma Receptor on Human Eosinophils , 1999, International Archives of Allergy and Immunology.

[210]  D. Broide,et al.  A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. , 1999, Journal of immunology.

[211]  D. Staunton,et al.  αdβ2 Integrin Is Expressed on Human Eosinophils and Functions as an Alternative Ligand for Vascular Cell Adhesion Molecule 1 (VCAM-1) , 1998, The Journal of experimental medicine.

[212]  C. Bruijnzeel-Koomen,et al.  Human eosinophils constitutively express a functional interleukin-4 receptor: interleukin-4 -induced priming of chemotactic responses and induction of PI-3 kinase activity. , 1998, American journal of respiratory cell and molecular biology.

[213]  Reinhard Jahn,et al.  Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution , 1998, Nature.

[214]  S. Bonini,et al.  Nerve growth factor is preformed in and activates human peripheral blood eosinophils. , 1998, The Journal of allergy and clinical immunology.

[215]  D. James,et al.  A novel synaptobrevin/VAMP homologous protein (VAMP5) is increased during in vitro myogenesis and present in the plasma membrane. , 1998, Molecular biology of the cell.

[216]  H. Tomioka,et al.  Heterogeneous Expression of Tumor Necrosis Factor-α Receptors I and II on Human Peripheral Eosinophils , 1998, International Archives of Allergy and Immunology.

[217]  T. Graf,et al.  PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. , 1998, Genes & development.

[218]  T. Graf,et al.  Distinct C/EBP functions are required for eosinophil lineage commitment and maturation. , 1998, Genes & development.

[219]  D. Loegering,et al.  Regulation and processing of a precursor form of eosinophil granule major basic protein (ProMBP) in differentiating eosinophils. , 1998, Blood.

[220]  T. Graf,et al.  Regulation of eosinophil‐specific gene expression by a C/EBP–Ets complex and GATA‐1 , 1998, The EMBO journal.

[221]  C. Martínez-A,et al.  The Coordinated Action of CC Chemokines in the Lung Orchestrates Allergic Inflammation and Airway Hyperresponsiveness , 1998, The Journal of experimental medicine.

[222]  K. Dyer,et al.  Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. , 1998, The Journal of infectious diseases.

[223]  H. Kita,et al.  Sulfonylureas inhibit cytokine-induced eosinophil survival and activation. , 1998, Journal of immunology.

[224]  J. Kazura,et al.  The role of eosinophils and neutrophils in helminth-induced keratitis. , 1998, Investigative ophthalmology & visual science.

[225]  T. Galli,et al.  A novel tetanus neurotoxin-insensitive vesicle-associated membrane protein in SNARE complexes of the apical plasma membrane of epithelial cells. , 1998, Molecular biology of the cell.

[226]  D. Friend,et al.  Eotaxin is required for the baseline level of tissue eosinophils. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[227]  C. O. Odigwe,et al.  Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. , 1998, Acta tropica.

[228]  E. Ruchelli,et al.  Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. , 1998, Journal of pediatric gastroenterology and nutrition.

[229]  T. Shimoyama,et al.  Infiltration of peroxidase-producing eosinophils into the lamina propria of patients with ulcerative colitis , 1998, Journal of Gastroenterology.

[230]  G. Furuta.  Eosinophils in the esophagus: acid is not the only cause. , 1998, Journal of pediatric gastroenterology and nutrition.

[231]  L. Koenderman,et al.  The role of transcription factor PU.1 in the activity of the intronic enhancer of the eosinophil-derived neurotoxin (RNS2) gene. , 1998, Blood.

[232]  W. Busse,et al.  Eosinophils bind rhinovirus and activate virus-specific T cells. , 1998, Journal of immunology.

[233]  Grant,et al.  High‐affinity immunoglobulin E receptor (FcεRI)‐bearing eosinophils, mast cells, macrophages and Langerhans’ cells in allergen‐induced late‐phase cutaneous reactions in atopic subjects , 1998, Immunology.

[234]  S. Yoshida,et al.  Human peripheral eosinophils express functional interferon‐gamma receptors (IFN‐γR) , 1997, Clinical and experimental immunology.

[235]  A. Tominaga,et al.  Marked eosinophilia in interleukin-5 transgenic mice fails to prevent Trichinella spiralis infection. , 1997, The Journal of parasitology.

[236]  C. Barlow,et al.  Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[237]  A. Proudfoot,et al.  The CC chemokine antagonist Met‐RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3 , 1997, European journal of immunology.

[238]  A. Fryer,et al.  Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. , 1997, The Journal of clinical investigation.

[239]  H. Kita,et al.  Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. , 1997, American journal of respiratory cell and molecular biology.

[240]  I. Nagaoka,et al.  Study on the superoxide-producing enzyme of eosinophils and neutrophils--comparison of the NADPH oxidase components. , 1997, Archives of biochemistry and biophysics.

[241]  S. Orkin,et al.  An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[242]  M. Heidtman,et al.  Human Peripheral Blood Eosinophils Express a Functional c-kit Receptor for Stem Cell Factor that Stimulates Very Late Antigen 4 (VLA-4)–mediated Cell Adhesion to Fibronectin and Vascular Cell Adhesion Molecule 1 (VCAM-1) , 1997, The Journal of experimental medicine.

[243]  J. Licht,et al.  Transcription factors, normal myeloid development, and leukemia. , 1997, Blood.

[244]  E. Gelfand,et al.  Interleukin-5 Expression in the Lung Epithelium of Transgenic Mice Leads to Pulmonary Changes Pathognomonic of Asthma , 1997, The Journal of experimental medicine.

[245]  P. Foster,et al.  Interleukin‐5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice , 1997, Immunology and cell biology.

[246]  S. Durham,et al.  Effect of cyclosporin A on the allergen-induced late asthmatic reaction. , 1997, Thorax.

[247]  J. D. Engel,et al.  GATA-1 transcription is controlled by distinct regulatory mechanisms during primitive and definitive erythropoiesis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[248]  K. Ovington,et al.  Eosinophilia, parasite burden and lung damage in Toxocara canis infection in C57Bl/6 mice genetically deficient in IL‐5 , 1997, Immunology.

[249]  F. Sundler,et al.  Allergic Eosinophil-rich Inflammation Develops in Lungs and Airways of B Cell–deficient Mice , 1997, The Journal of experimental medicine.

[250]  M. Isobe,et al.  Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis. , 1997, Internal medicine.

[251]  R. Garofalo,et al.  Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. , 1997, The Journal of infectious diseases.

[252]  K. Shirato,et al.  Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. , 1997, American journal of respiratory cell and molecular biology.

[253]  P. Leder,et al.  Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia , 1997, The Journal of experimental medicine.

[254]  D. Tenen,et al.  Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[255]  M. Cybulsky,et al.  Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. , 1996, The Journal of clinical investigation.

[256]  N. Ishii,et al.  Requirement of CD80 and CD86 Molecules for Antigen Presentation by Eosinophils , 1996, Scandinavian journal of immunology.

[257]  S. Bischoff,et al.  Mucosal allergy: role of mast cells and eosinophil granulocytes in the gut. , 1996, Bailliere's clinical gastroenterology.

[258]  E. Wang,et al.  Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview. , 1996, Archives of pediatrics & adolescent medicine.

[259]  F. Symon,et al.  Functional and structural characterization of the eosinophil P-selectin ligand. , 1996, Journal of immunology.

[260]  P. Roche,et al.  Identification of a Novel Syntaxin- and Synaptobrevin/VAMP-binding Protein, SNAP-23, Expressed in Non-neuronal Tissues* , 1996, The Journal of Biological Chemistry.

[261]  C. Mackay,et al.  Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils , 1996, The Journal of experimental medicine.

[262]  J. Demartino,et al.  Cloning, expression, and characterization of the human eosinophil eotaxin receptor , 1996, The Journal of experimental medicine.

[263]  J. Miyazaki,et al.  Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. , 1996, Immunity.

[264]  M. Jordana,et al.  CD40 expression by human peripheral blood eosinophils. , 1996, The Journal of clinical investigation.

[265]  H. Kita.  The eosinophil: a cytokine-producing cell? , 1996, The Journal of allergy and clinical immunology.

[266]  F. Symon,et al.  Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor. , 1996, Blood.

[267]  A. Capron,et al.  Eosinophils express a functional receptor for interferon alpha: inhibitory role of interferon alpha on the release of mediators. , 1996, Blood.

[268]  A. Slungaard,et al.  Effect of eosinophil peroxidase on airway epithelial permeability in the guinea pig , 1996, Pediatric pulmonology.

[269]  M. Soresi,et al.  Gastroesophageal reflux and cow's milk allergy in infants: a prospective study. , 1996, The Journal of allergy and clinical immunology.

[270]  J. Murray,et al.  A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings. , 1996, The Journal of allergy and clinical immunology.

[271]  P. Foster,et al.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model , 1996, The Journal of experimental medicine.

[272]  R. Scheller,et al.  VAMP/synaptobrevin isoforms 1 and 2 are widely and differentially expressed in nonneuronal tissues , 1996, The Journal of cell biology.

[273]  G. Gleich,et al.  Analysis of signaling events associated with activation of neutrophil superoxide anion production by eosinophil granule major basic protein. , 1995, Blood.

[274]  H. Sampson,et al.  Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. , 1995, Gastroenterology.

[275]  M. Tian,et al.  A survey of GTP-binding proteins and other potential key regulators of exocytotic secretion in eosinophils. Apparent absence of rab3 and vesicle fusion protein homologues. , 1995, Journal of cell science.

[276]  T. Williams,et al.  Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo , 1995, The Journal of experimental medicine.

[277]  K. Matsumoto,et al.  Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. , 1995, Blood.

[278]  R. Egan,et al.  Effects of an antibody to interleukin-5 in a monkey model of asthma. , 1995, American journal of respiratory and critical care medicine.

[279]  O. Masamune,et al.  [A case of eosinophilic gastroenteritis accompanied by perimyocarditis, which was strongly suspected]. , 1995, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[280]  I. Adcock,et al.  Steroid resistance in asthma. , 1995, QJM : monthly journal of the Association of Physicians.

[281]  W. Owen,et al.  Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate , 1995, The Journal of experimental medicine.

[282]  A. Capron,et al.  Eosinophils: from low‐ to high‐affinity immunoglobulin E receptors , 1995, Allergy.

[283]  T. Hugli,et al.  C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation , 1995, The Journal of experimental medicine.

[284]  K. Dyer,et al.  Rapid evolution of a unique family of primate ribonuclease genes , 1995, Nature Genetics.

[285]  A. Kapp,et al.  Subcellular mechanisms of eosinophil degranulation: the role of RANTES, interleukin-5 and tumor necrosis factor-alpha. , 1995, International archives of allergy and immunology.

[286]  R. Egan,et al.  Inhibition of pulmonary eosinophilia and hyperreactivity by antibodies to interleukin-5. , 1995, International archives of allergy and immunology.

[287]  W. Powell,et al.  5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration. , 1995, Journal of immunology.

[288]  P. Leder,et al.  Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung , 1995, The Journal of experimental medicine.

[289]  P. Bozeman,et al.  Oxidation of Bromide by the Human Leukocyte Enzymes Myeloperoxidase and Eosinophil Peroxidase , 1995, The Journal of Biological Chemistry.

[290]  J. Weiler,et al.  Eosinophil granule cationic proteins regulate the classical pathway of complement. , 1995, Immunology.

[291]  R. Odze,et al.  Allergic colitis in infants. , 1995, The Journal of pediatrics.

[292]  P. Dri,et al.  Hereditary eosinophil peroxidase deficiency: immunochemical and spectroscopic studies and evidence for a compound heterozygosity of the defect. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[293]  F. Symon,et al.  Mechanisms of eosinophil and basophil migration , 1994, Allergy.

[294]  R. Schleimer,et al.  The effects of glucocorticoids on human eosinophils. , 1994, The Journal of allergy and clinical immunology.

[295]  E. Butcher,et al.  L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo. , 1994, Journal of immunology.

[296]  P. Brown,et al.  Eosinophilic endomyocardial disease due to high grade chest wall sarcoma. , 1994, Thorax.

[297]  P. Ind,et al.  Non‐invasive assessment of bronchial inflammation in asthma: no correlation between eosinophilia of induced sputum and bronchial responsiveness to inhaled hypertonic saline , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[298]  R. Schleimer,et al.  The role of adhesion molecules in human eosinophil and basophil recruitment. , 1994, The Journal of allergy and clinical immunology.

[299]  B. Vargaftig,et al.  Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways , 1994, The Journal of experimental medicine.

[300]  A. Kapp,et al.  TNFα‐induced activation of eosinophil oxidative metabolism and morphology ‐ Comparison with IL‐5 * , 1994 .

[301]  J. Kazura,et al.  Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation. , 1994, Immunology.

[302]  H Nakajima,et al.  Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue , 1994, The Journal of experimental medicine.

[303]  J. Hsuan,et al.  Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation , 1994, The Journal of experimental medicine.

[304]  P. Weller,et al.  Eosinophils: structure and functions. , 1994, Current opinion in immunology.

[305]  C. Benjamin,et al.  Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. , 1994, The Journal of clinical investigation.

[306]  E. Johnson,et al.  Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate-early gene induction. , 1994, The Journal of biological chemistry.

[307]  E. Berg,et al.  L-selectin-mediated lymphocyte rolling on MAdCAM-1 , 1993, Nature.

[308]  M. Cooper,et al.  Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. , 1993, The Journal of clinical investigation.

[309]  F. Gaeta,et al.  Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration , 1993, The Journal of experimental medicine.

[310]  K. Ishida,et al.  Ablation of eosinophils with anti‐IL‐5 antibody enhances the survival of intracranial worms of Angiostrongylus cantonensis in the mouse , 1993, Parasite immunology.

[311]  Paul Tempst,et al.  SNAP receptors implicated in vesicle targeting and fusion , 1993, Nature.

[312]  D. Wong,et al.  Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. , 1993, Journal of immunology.

[313]  S. Nourshargh,et al.  A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo , 1993, The Journal of experimental medicine.

[314]  W. Busse,et al.  Comparison of airway and blood eosinophil function after in vivo antigen challenge. , 1992, Journal of immunology.

[315]  S. Kayes,et al.  Depletion of eosinophils by anti-IL-5 monoclonal antibody treatment of mice infected with Trichinella spiralis does not alter parasite burden or immunologic resistance to reinfection. , 1992, Journal of immunology.

[316]  S. Georas,et al.  Altered adhesion molecule expression and endothelial cell activation accompany the recruitment of human granulocytes to the lung after segmental antigen challenge. , 1992, American journal of respiratory cell and molecular biology.

[317]  J. Fehr,et al.  IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. , 1992, Journal of immunology.

[318]  P. Chanez,et al.  Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. , 1992, The Journal of allergy and clinical immunology.

[319]  W. Busse,et al.  Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma. , 1992, The American review of respiratory disease.

[320]  J. Weiler,et al.  Eosinophil granule cationic proteins regulate complement. I. Activity on the alternative pathway. , 1992, Journal of immunology.

[321]  A. Woolcock,et al.  Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation. , 1992, The American review of respiratory disease.

[322]  A. Chevailler.  [Cytokines and allergy]. , 1992, Allergie et immunologie.

[323]  A. Wardlaw,et al.  IFN-gamma induces expression of Fc gamma RIII (CD16) on human eosinophils. , 1992, Journal of immunology.

[324]  T. Gaginella,et al.  The eosinophil in inflammatory bowel disease. , 1991, Scandinavian journal of gastroenterology.

[325]  H. Kita,et al.  Glucocorticoids inhibit cytokine-mediated eosinophil survival. , 1991, Journal of immunology.

[326]  J. Braunstein,et al.  Sputum eosinophils from asthmatics express ICAM‐1 and HLA‐DR , 1991, Clinical and experimental immunology.

[327]  D. Metcalf.  Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. , 1991, Science.

[328]  P. Weller,et al.  Human eosinophils express functional interleukin 2 receptors. , 1991, The Journal of clinical investigation.

[329]  T. Kuijpers,et al.  Characteristics of CR3-mediated aggregation in human eosinophils: effect of priming by platelet-activating factor. , 1991, The Journal of allergy and clinical immunology.

[330]  H. Kita,et al.  Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate. , 1991, Journal of immunology.

[331]  N. Yamaguchi,et al.  The role of interleukin-5 in protective immunity to Strongyloides venezuelensis infection in mice. , 1991, Immunology.

[332]  G. Gleich,et al.  Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. , 1991, The Journal of clinical investigation.

[333]  J. Mahoney,et al.  Thiocyanate is the major substrate for eosinophil peroxidase in physiologic fluids. Implications for cytotoxicity. , 1991, The Journal of biological chemistry.

[334]  J. Miyazaki,et al.  Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production , 1991, The Journal of experimental medicine.

[335]  A. Wardlaw,et al.  IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils. , 1990, Journal of immunology.

[336]  R. Coffman,et al.  Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. , 1990, Journal of immunology.

[337]  V. Brusasco,et al.  Allergen-induced increase in airway responsiveness and inflammation in mild asthma. , 1990, Journal of applied physiology.

[338]  M. Strath,et al.  Eosinophilia in transgenic mice expressing interleukin 5 , 1990, The Journal of experimental medicine.

[339]  C. Wheatley,et al.  Activation of platelets by eosinophil granule proteins , 1990, The Journal of experimental medicine.

[340]  M. Heise,et al.  Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily. , 1990, Genomics.

[341]  G. Gleich,et al.  Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitro. , 1990, The Journal of allergy and clinical immunology.

[342]  A. Kay,et al.  Receptor expression and functional status of cultured human eosinophils derived from umbilical cord blood mononuclear cells. , 1990, Blood.

[343]  A. Kay,et al.  Fc gamma and CD11/CD18 receptor expression on normal density and low density human eosinophils. , 1990, Immunology.

[344]  R. Rothlein,et al.  Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. , 1990, Science.

[345]  S. Hill,et al.  Colitis caused by food allergy in infants. , 1990, Archives of disease in childhood.

[346]  C. Sanderson.  Eosinophils. A Comprehensive Review and Guide to the Scientific and Medical Literature , 1989 .

[347]  R. L. Barker,et al.  Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases. , 1989, Journal of immunology.

[348]  R. Coffman,et al.  Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. , 1989, Science.

[349]  D. Tenen,et al.  Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity , 1989, The Journal of experimental medicine.

[350]  A. Sheffer,et al.  Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome , 1989, The Journal of experimental medicine.

[351]  T. Ganz,et al.  Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. , 1989, Journal of immunology.

[352]  L. Pease,et al.  Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family , 1989, The Journal of experimental medicine.

[353]  A. N. Mayeno,et al.  Eosinophils preferentially use bromide to generate halogenating agents. , 1989, The Journal of biological chemistry.

[354]  R. Kyle,et al.  IgA-induced eosinophil degranulation. , 1989, Journal of immunology.

[355]  Daniel Lucey,et al.  Mature human eosinophils have the capacity to express HLA-DR. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[356]  C. Nathan,et al.  Isolation of a complementary DNA clone encoding a precursor to human eosinophil major basic protein , 1988, The Journal of experimental medicine.

[357]  A. Capron,et al.  Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. , 1988, Clinical and experimental immunology.

[358]  A. Kay,et al.  Leukotriene C4 generation from human eosinophils stimulated with IgG-Aspergillus fumigatus antigen immune complexes. , 1988, The Journal of allergy and clinical immunology.

[359]  R. L. Barker,et al.  Acidic precursor revealed in human eosinophil granule major basic protein cDNA [published erratum appears in J Exp Med 1989 Sep 1;170(3):1057] , 1988, The Journal of experimental medicine.

[360]  W. Owen,et al.  Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factor. , 1988, The Journal of biological chemistry.

[361]  D. Loegering,et al.  Biochemical and amino acid sequence analysis of human eosinophil granule major basic protein. , 1988, The Journal of biological chemistry.

[362]  J. Gamble,et al.  Recombinant human interleukin 5 is a selective activator of human eosinophil function , 1988, The Journal of experimental medicine.

[363]  R. L. Barker,et al.  Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis. , 1987, The Journal of parasitology.

[364]  S. Sarin,et al.  Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis , 1987, Digestive Diseases and Sciences.

[365]  D. Loegering,et al.  Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. , 1986, Journal of immunology.

[366]  I. Olsson,et al.  Localization of eosinophil cationic protein, major basic protein, and eosinophil peroxidase in human eosinophils by immunoelectron microscopic technique. , 1986, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[367]  S. Weiss,et al.  Brominating oxidants generated by human eosinophils. , 1986, Science.

[368]  P. Venge,et al.  Mechanism of membrane damage mediated by human eosinophil cationic protein , 1986, Nature.

[369]  Moses Rodriguez,et al.  Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[370]  D. Loegering,et al.  Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[371]  M. Vadas,et al.  Murine eosinophil differentiation factor. An eosinophil-specific colony- stimulating factor with activity for human cells , 1986, The Journal of experimental medicine.

[372]  M. Kazatchkine,et al.  Human eosinophils express CR1 and CR3 complement receptors for cleavage fragments of C3. , 1986, Cellular immunology.

[373]  Saavedra-Delgado Am,et al.  Interactions between food antigens and the immune system in the pathogenesis of gastrointestinal diseases. , 1985 .

[374]  U. Blumenthal,et al.  Eosinophilia and resistance to Schistosoma haematobium in man , 1985, Parasite immunology.

[375]  D. Loegering,et al.  Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. , 1985, The American journal of tropical medicine and hygiene.

[376]  A. Capron,et al.  Cytophilic IgE on human blood and tissue eosinophils: detection by flow microfluorometry. , 1985, Journal of immunology.

[377]  N. Oyaizu,et al.  Eosinophilic gastroenteritis. Immunohistochemical evidence for IgE mast cell-mediated allergy. , 1985, Acta pathologica japonica.

[378]  A. Keshavarzian,et al.  Activated eosinophils in familial eosinophilic gastroenteritis. , 1985, Gastroenterology.

[379]  D. Antonioli,et al.  Intraepithelial eosinophils in endoscopic biopsies of adults with reflux esophagitis , 1984, The American journal of surgical pathology.

[380]  G. Gleich,et al.  Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. , 1984, Journal of immunology.

[381]  K. Benirschke,et al.  Localization of a molecule immunochemically similar to eosinophil major basic protein in human placenta , 1984, The Journal of experimental medicine.

[382]  T. Habermann,et al.  Localization of eosinophil granule major basic protein in human basophils , 1983, The Journal of experimental medicine.

[383]  G. Gleich,et al.  Activation of basophil and mast cell histamine release by eosinophil granule major basic protein , 1983, The Journal of experimental medicine.

[384]  R. Dahl,et al.  The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. , 1982, The Journal of allergy and clinical immunology.

[385]  H. Goldman,et al.  Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. , 1982, Gastroenterology.

[386]  G. Gleich,et al.  Food allergy manifested by eosinophilia, elevated immunoglobulin E level, and protein-losing enteropathy: the syndrome of allergic gastroenteropathy. , 1982, The Journal of allergy and clinical immunology.

[387]  M. Sherman,et al.  Neonatal eosinophilic colitis. , 1982, The Journal of pediatrics.

[388]  I. Olsson,et al.  Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro , 1981, Parasite immunology.

[389]  A. Dvorak.  Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo: cytotoxic potential in Crohn's disease. , 1980, Journal of immunology.

[390]  J. Cello.  Eosinophilic gastroenteritis--a complex disease entity. , 1979, The American journal of medicine.

[391]  S. M. Sumi,et al.  Neurotoxicity of human eosinophils. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[392]  J B Watson,et al.  Food allergy Response to treatment with sodium cromoglycate , 2006 .

[393]  D. Loegering,et al.  Localization of the guinea pig eosinophil major basic protein to the core of the granule , 1978, The Journal of cell biology.

[394]  D. Cockcroft,et al.  Allergen‐induced increase in non‐allergic bronchial reactivity , 1977, Clinical allergy.

[395]  T. Nutman,et al.  Schistosoma mansoni: resistance to reinfection in the rat. , 1977, Experimental parasitology.

[396]  J. Caldwell,et al.  Serum IgE in eosinophilic gastroenteritis. Response to intestinal challenge in two cases. , 1975, The New England journal of medicine.

[397]  D. Franks,et al.  Nonspecific cytotoxic effects of antigen-transformed lymphocytes. III. Relationship to specific cytotoxicity. , 1975, Cellular immunology.

[398]  S. Wolff,et al.  THE HYPEREOSINOPHILIC SYNDROME: Analysis of Fourteen Cases With Review of The Literature , 1975, Medicine.

[399]  D. Loegering,et al.  IDENTIFICATION OF A MAJOR BASIC PROTEIN IN GUINEA PIG EOSINOPHIL GRANULES , 1973, The Journal of experimental medicine.

[400]  B. Bain,et al.  Hypereosinophilia. , 2009, Blood.

[401]  Anand Gupte,et al.  Eosinophilic esophagitis. , 2009, World journal of gastroenterology.

[402]  F. Kalkbrenner,et al.  Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma. , 2007, American journal of respiratory cell and molecular biology.

[403]  S. Siddiqui,et al.  Immune responses to viral infections: relevance for asthma. , 2006, Paediatric respiratory reviews.

[404]  A. Sher,et al.  Mechanisms underlying helminth- induced Th2 polarization: default, negative or positive pathways? , 2006, Chemical immunology and allergy.

[405]  H. Rosenberg,et al.  The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention. , 2005, Pharmacology & therapeutics.

[406]  P. Foster,et al.  Chemokines in eosinophil-associated gastrointestinal disorders , 2004, Current allergy and asthma reports.

[407]  Jae-Hoon Lee,et al.  The suggestive association of eotaxin-2 and eotaxin-3 gene polymorphisms in Korean population with allergic rhinitis , 2004, Immunogenetics.

[408]  K. Sommers,et al.  Effect of cetirizine, ketotifen and chlorpheniramine on the dynamics of the cutaneous hypersensitivity reaction: a comparative study , 2004, European Journal of Clinical Pharmacology.

[409]  J. Boyce,et al.  Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. , 2004, The Journal of allergy and clinical immunology.

[410]  T. Nutman,et al.  The role of eosinophils in host defense against helminth parasites. , 2004, The Journal of allergy and clinical immunology.

[411]  E. Bel.  Clinical phenotypes of asthma. , 2004, Current opinion in pulmonary medicine.

[412]  P. O'Byrne,et al.  Sputum CD34+IL-5Ralpha+ cells increase after allergen: evidence for in situ eosinophilopoiesis. , 2004, American journal of respiratory and critical care medicine.

[413]  H Phillip Koeffler,et al.  Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBP epsilon and PU.1. , 2003, Blood.

[414]  Eric J Kunkel,et al.  Chemokines and the tissue-specific migration of lymphocytes. , 2002, Immunity.

[415]  S. Dower,et al.  Toll-Like Receptor (TLR)2 and TLR4 in Human Peripheral Blood Granulocytes: A Critical Role for Monocytes in Leukocyte Lipopolysaccharide Responses , 2002 .

[416]  M. Rothenberg,et al.  Gastrointestinal eosinophils in health and disease. , 2001, Advances in immunology.

[417]  H. Behrendt,et al.  The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent. , 2001, Blood.

[418]  G. Burkland,et al.  Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate. , 2001, MedGenMed : Medscape general medicine.

[419]  S. Rankin,et al.  Eotaxin and eosinophil recruitment: implications for human disease. , 2000, Molecular medicine today.

[420]  Paige Lacy,et al.  Eosinophil cytokines. , 2000, Chemical immunology.

[421]  R. Dummer,et al.  Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. , 1999, The New England journal of medicine.

[422]  V. Brusasco,et al.  Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. , 1998, American journal of respiratory and critical care medicine.

[423]  Paige Lacy,et al.  Eokines: synthesis, storage and release from human eosinophils. , 1997, Memorias do Instituto Oswaldo Cruz.

[424]  H. Kita,et al.  Eosinophils and IgE receptors: a continuing controversy. , 1997, Blood.

[425]  P. Hodgkin,et al.  IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. , 1996, Immunity.

[426]  E. Kaldjian,et al.  Orchestrated information transfer underlying leukocyte endothelial interactions. , 1996, Annual review of immunology.

[427]  R. Sturrock,et al.  Schistosomiasis mansoni in Kenya: relationship between infection and anaemia in schoolchildren at the community level. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[428]  R. Kleinman,et al.  Allergic gastroenteropathy in children. , 1995, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[429]  S. Ackerman,et al.  The role of the eosinophil in gastrointestinal diseases , 1995 .

[430]  Y. Hitoshi,et al.  Interleukin-5 and its receptor system: implications in the immune system and inflammation. , 1994, Advances in immunology.

[431]  P. Murphy.  The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.

[432]  A. Kapp,et al.  TNF alpha-induced activation of eosinophil oxidative metabolism and morphology--comparison with IL-5. , 1994, Experimental dermatology.

[433]  G. Larsen,et al.  The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo. A comparison with polycations. , 1993, The American review of respiratory disease.

[434]  C. Irvin,et al.  Cationic proteins induce airway hyperresponsiveness dependent on charge interactions. , 1993, The American review of respiratory disease.

[435]  D. Jones.  The eosinophil. , 1993, Journal of comparative pathology.

[436]  S. Georas,et al.  Expression of a functional laminin receptor (alpha 6 beta 1, very late activation antigen-6) on human eosinophils. , 1993, Blood.

[437]  R. Garofalo,et al.  Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. , 1992, The Journal of pediatrics.

[438]  C. Sanderson,et al.  Interleukin-5, eosinophils, and disease. , 1992, Blood.

[439]  R. L. Barker,et al.  The molecular biology of eosinophil granule proteins. , 1991, International archives of allergy and applied immunology.

[440]  A. Kay,et al.  Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. , 1991, The American review of respiratory disease.

[441]  R. Coffman,et al.  Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[442]  C. Spry.  Eosinophils : a comprehensive review, and guide to the scientific and medical literature , 1988 .

[443]  J. Gamble,et al.  Nedocromil sodium and cromolyn (sodium cromoglycate) selectively inhibit antibody-dependent granulocyte-mediated cytotoxicity. , 1988, International archives of allergy and applied immunology.

[444]  G. Gleich,et al.  The eosinophilic leukocyte: structure and function. , 1986, Advances in immunology.

[445]  D. Metcalfe,et al.  Interactions between food antigens and the immune system in the pathogenesis of gastrointestinal diseases. , 1985, Annals of allergy.

[446]  D. Loegering,et al.  Immunobiology of eosinophils. , 1984, Annual review of immunology.

[447]  A. Butterworth.  Cell-mediated damage to helminths. , 1984, Advances in parasitology.

[448]  R. Sturrock,et al.  Observations on possible immunity to reinfection among Kenyan schoolchildren after treatment for Schistosoma mansoni. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[449]  D. Loegering,et al.  Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. , 1980, Laboratory investigation; a journal of technical methods and pathology.

[450]  A. Glauert,et al.  Morphological evidence for the ability of eosinophils to damage antibody-coated schistosomula. , 1977, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[451]  R. Good,et al.  Surface markers of human eosinophils. , 1976, Blood.

[452]  S. Wolff,et al.  The hypereosinophilic syndrome , 1975 .